7 Papers
6 Citations
Yinli Yang is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune
TL;DR: Ginsenoside Rg3 could be regarded as a new agent targeting PD-L1 in chemotherapy refractory NSCLC and inhibit the growth and alleviate the resistant to cisplatin of A549/DDP cells.
121
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
TL;DR: A role for anlotinib in the innate immune cells in the tumor microenvironment and a potentially synergistic anti-tumor combination with immune checkpoint inhibition are described.
87
Apatinib prevents natural killer cell dysfunction to enhance the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
TL;DR: Treatment with apatinib resulted in attenuation of tumor growth and increased tumor vessel normalization and results indicated that natural killer cells, but not CD4 + or CD8 + T cells mediated the therapeutic efficacy of apatinIB in HCC mouse models.
27
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitors
TL;DR: The purpose of this study was to compare the effects of pemetrexed and carboplatin plus bevacizumab (PC + B) versus pemetrixed and Carboplatin (PC) in lung adenocarcinoma patients with EGFR non‐T790M mutations after progression on first‐line EGFR‐tyrosine kinase inhibitors (TKIs).
7
The Combinatorial Effect of Cisplatin and Moxibustion on Tumor Growth Inhibition with Special Reference to Modulation of the Immune Microenvironment in Lewis Lung Cancer Mice.
Bin Wang,Bin Wang,Jin Huang,Shanshan Li,Zhanyu Pan,Yongming Guo,Yinli Yang,Ling Li,Cong Wang,Yinan Gong,Jiaqi Wang,Shanshan Lu,Zhifang Xu,Yi Guo +13 more
TL;DR: In this paper, the authors explored the antitumor effects and potential mechanisms of combinatorial cisplatin and moxibustion treatment for non-small cell lung cancer (NSCLC) by targeting the tumor microenvironment.